Company Profile for StemCell Pharma, Inc.Today 4 million have been diagnosed in the U. S. alone as suffering from Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. . Of that total, approximately ap·prox·i·mate adj. 1. Almost exact or correct: the approximate time of the accident. 2. 2.25 million Americans are in the early (I-III) stages. Presently, there are only about five drugs approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for treatment, with the results of these drugs being less than satisfactory. This growing crisis challenges the medical profession to look for effective ways of handling this disease. StemCell Pharma, Inc. believes that the beneficial results of its proprietary treatment will benefit positively not only this large group of patients, but also the highly stressed families of these patients who are burdened with their care. Stemcell Pharma, Inc. has developed an innovative, proprietary placenta/stem cells "Implant implant /im·plant/ (im-plant´) to insert or to graft (tissue, or inert or radioactive material) into intact tissues or a body cavity. " technique that presents a new alternative approach and represents the cutting edge in the treatment of early Alzheimer's Noun 1. Alzheimer's - a progressive form of presenile dementia that is similar to senile dementia except that it usually starts in the 40s or 50s; first symptoms are impaired memory which is followed by impaired thought and speech and finally complete helplessness . Without the need for FDA approval and a physician-based target market, StemCell Pharma, Inc. is positioned as a leader in the early treatment of Alzheimer's. Investors have a ground floor opportunity to not only make an excellent return projected up to 10 times within five years on their investment but also to help alleviate Alleviate To make something easier to be endured. Mentioned in: Kinesiology, Applied one of mankind's most destructive diseases.
Company: StemCell Pharma, Inc.
Headquarters Address: 3526 Leor Court
Las Vegas, NV 89121
Main Telephone: (312) 474-9800
Website: www.StemCellPharma.com
Type of Organization: Private
Industry: Health: Pharmaceutical
Key Executives: President: Alfred T. Sapse, MD (r)
Investor Relations
Contact: John Paul Owles
Phone: (312) 474-9800
Email: JPO@StemCellPharma.com
Public Relations
Contact: John Paul Owles
Phone: (312) 474-9800
Email: JPO@StemCellPharma.com
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion